← All trials

NCT06885762

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Apr 13, 2025
Primary completion
Jun 30, 2026
Completion date
Dec 31, 2026
First posted
Mar 20, 2025
Last posted
Mar 20, 2025
Enrollment
20
Arms / groups
1 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.